DNA-repair machine maintains genomic stability

June 05, 2000



The fidelity of the genome is under constant threat - toxic chemicals, ionizing radiation, even the byproducts of normal cellular metabolism can wreak havoc on DNA. In some instances, DNA damage is severe enough to chop the double helix in two. When this happens, a group of proteins that fixes double-stranded DNA breaks mobilizes to make repairs. If a break goes unfixed, the consequences to the cell can be disastrous, ranging from wholesale gene rearrangements to massive chromosomal breakdown.

Humans and other organisms are fortunate to have several repair systems that monitor DNA for signs of damage and initiate repairs when they are needed. HHMI investigator Frederick W. Alt and colleagues at Children's Hospital in Boston, Harvard Medical School and the Dana-Farber Cancer Institute are delving into these repair mechanisms and learning how the systems work and why they sometimes fail.

In a research article published in the June 2000 issue of Proceedings of the National Academy of Sciences, Alt and his colleagues report that mouse cells that lack a functioning nonhomologous DNA end-joining (NHEJ) pathway - which rejoins the broken ends of double-stranded DNA - show high levels of chromosome breakage and rearrangement of genetic material, called translocations. Such translocations are a frequent cause of leukemias and lymphomas. The take-home message from these studies, said Alt, is that the NHEJ repair pathway is critical to maintaining genomic stability.

In previous studies, Alt and his colleagues found that NHEJ is responsible for rejoining double-stranded DNA breaks in cells exposed to ionizing radiation and in lymphocytes that undergo gene shuffling during the process of creating infection-fighting cells. Those experiments revealed that mice missing a key component of the NHEJ pathway suffered higher rates of B cell lymphoma, a cancer that is caused by the translocation of specific genes. So, Alt and his colleagues decided to see if NHEJ had a wider role in maintaining genomic stability.

"That finding of an increased rate of this particular translocation-related type of cancer led us to wonder whether a lack of end-joining could somehow predispose cells to genomic instability in general," said Alt. "If this were true, malfunctions in the NHEJ pathway might have more general implications for carcinogenesis."

The scientists examined embryonic mouse fibroblast cells that were deficient in one of three key enzymes (DNA-PKcs, Ku70 and Lig4) from the NHEJ repair pathway.

"We chose embryonic fibroblasts rather than tumor cells because we wanted to use cells that were as close to normal as possible," said Alt.

Using a new chromosome-imaging technique called spectral karotyping, the researchers were able to spot the location of breaks in the otherwise featureless chromosomal landscape. In this procedure, researchers treat cells with fluorescent DNA probes that attach to specific DNA sequences on chromosomes. These colored probes paint each chromosome with a slightly different hue. A computerized imaging system attached to a microscope is then used to scan the cells. Looking through the microscope, a researcher can look for color differences to distinguish between the different chromosomes. The technique labels whole chromosomes and fragments of chromosomes, thus making the job of spotting broken pieces of DNA or chromosome rearrangements considerably easier.

"When David Ferguson used this detection technique, he found no chromosome abnormalities in the wild-type cells," said Alt. "When he looked at the NHEJ-defective cells, however, he saw a dramatic increase in chromosomal abnormalities in the cells that lacked Lig4 or Ku70. He also saw a smaller increase in abnormalities in the DNA-PKcs-deficient cells."

Alt and his colleagues also examined tissue directly from mice, noting the same kinds of abnormalities that they had seen in cultured cells.

In an experiment designed to assess the role of the NHEJ pathway in repairing general chromosomal damage induced by radiation, the scientists irradiated fibroblast cells that were deficient in both Lig4 and p53, a key DNA damage sensor. Normally, p53 prevents damaged cells from proceeding in the cell division cycle.

"We found a huge number of damaged chromosomes in the cells that were deficient in both Lig4 and p53 as compared to those deficient in only p53," said Alt. "Just about every chromosome had been broken to bits. This clearly shows that the end-joining pathway is extremely important in rejoining the ends of chromosomes damaged by ionizing radiation. If you don't have it, the cells are in big trouble."

Previous studies of chromosome repair suggested that a second repair pathway, the homologous recombination pathway, might be the major pathway responsible for accurate repair of damaged DNA because it seeks to match up DNA sequences when rejoining broken segments. Alt pointed out that this may not be the case, since his group's experiments show that translocations were infrequent in wild-type cells irradiated heavily enough to cause a high level of such damage in NHEJ-defective cells in which the homologous recombination pathway should be unaffected.

Howard Hughes Medical Institute

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.